Switzerland · Series C startup

Who invested in Asceneuron

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$131Mraised across 2 rounds since 2015, from 2 sources

$31MSeries A$100MSeries C
Latest round
Series C, $100MJul 2024
Step-upi
3.3×
Investors
7
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2017201920212023
$31MSeries A$100MSeries C
First round
Series A, $31M
Sept 2015
Biggest round
$100M
Series C · Jul 2024
Between rounds
8.8 years
from the last two

The rounds

  1. Jul 2024
    Series C$100M3 new2 returning

    Source recorded

  2. Sept 2015
    Series A$31M4 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Sofinnova PartnersVC firm2rounds
SR OneCorporate VC2rounds
OrbiMedPrivate equity1round
Novo HoldingsVC firm1round
KurmaPartnersVC firm1round
Johnson & Johnson InnovationGrowth equity1round
MS VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Asceneuron

Who invested in Asceneuron?

Asceneuron's investors include Sofinnova Partners, SR One, OrbiMed, Novo Holdings and KurmaPartners, and 2 more on record.

How much has Asceneuron raised?

Asceneuron has raised $131M across 2 rounds since 2015.

When did Asceneuron last raise?

Asceneuron's most recent round was a Series C of $100M in Jul 2024.

What was Asceneuron's biggest round?

Its most recent round, $100M in Jul 2024, is also its largest on record.

Who backed Asceneuron first?

Asceneuron's first round on record, in Sept 2015, was backed by Sofinnova Partners, SR One and Johnson & Johnson Innovation and 1 others.

What stage is Asceneuron at?

Asceneuron's latest named round is a Series C, in Jul 2024.

Where is Asceneuron based?

Asceneuron is based in Switzerland.

Companies like Asceneuron

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.